Clinical Trials Logo

Filter by:
NCT ID: NCT04381000 Completed - Chronic Pain Clinical Trials

Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The quarantine during COVID-19 pandemic has changed daily routine. Staying at home for prolonged periods of time can pose a significant challenge for patients with chronic pain. The purpose of the current study is to investigate how the quarantine effects of psychosocial factors, quality of life, sleep, nutrition and physical activity in patients with chronic musculoskeletal pain. Another purpose is to examine whether a telerehabilitation exercise program is effective during the lockdown period.

NCT ID: NCT04382820 Completed - Rare Diseases Clinical Trials

Psychosocial Situation of Children With Rare (Congenital) Pediatric Surgical Diseases and Their Families

Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

Families of children with rare diseases (i.e., not more than 5 out of 10.000 people are affected) are often highly burdened with fears, insecurities and concerns regarding the affected child and his/her siblings. The aim of the present research project is to examine the psychosocial burden of the children with rare (congenital) pediatric surgical diseases and their family in order to draw attention to a possible psychosocial care gap in this population.

NCT ID: NCT04384380 Completed - Clinical trials for Coronavirus Infection

Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The effective medical treatment against COVID-19 infection is still unknown. Chloroquine phosphate is a well-known antimalarial drug which has been on the market for many years. Recently, in vitro study shown that Chloroquine is effective at both entry and at post-entry stages of the COVID-19 infection of Vero E6 cells with promising results. Chloroquine is also an immune-modifier and could distribute to the whole body including lung. Also, chloroquine is cheap and safe, and could be a promising agent against COVID-19 infection. However, only hydroxychloroquine (HCQ) with the extra hydroxyl group is available in Taiwan. Therefore, hydroxychloroquine instead become the best choice for the treatment candidate, since it shows higher in vitro potency (EC50) against COVID-19 with lower toxicity while retaining the original effect which compared with chloroquine.

NCT ID: NCT04384406 Completed - COVID-19 Clinical Trials

COVID-19 Outbreak Consequences for Outpatients Followed in PRM

Handicall
Start date: April 1, 2020
Phase:
Study type: Observational

Objectives This survey aims at reporting the immediate impact of the COVID-19 epidemic on outpatients followed in Physical and Rehabilitation Medicine (PRM). It focuses on the disruption of PRM healthcare services during the quarantine period in France between 2020 March 17th and May 11th and on its medical consequences. Method This observational study was conducted in the PRM department of a French University Hospital. Outpatients whose PRM medical consultation had been cancelled were contacted by phone between April 9th, 2020 and May 7th, 2020. A structured questionnaire was fulfilled for each patient. Demographical and medical data were recorded, including the disabling diseases motivating the PRM outpatients' follow-up. The necessity to perform an immediate phone consultation or to schedule an urgent consultation within the next 3 weeks constituted the main judgment criterion. Other recorded criteria were: the reason for this urgent need of a medical consultation, the access to other medical services during the quarantine period, the interruption of home-based rehabilitation services and its perceived consequences for the patients.

NCT ID: NCT04392141 Completed - COVID-19 Clinical Trials

Colchicine Plus Phenolic Monoterpenes to Treat COVID-19

Start date: April 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

In this randomized controlled clinical trial, defined cases of COVID-19 with mild, moderate, or severe pneumonia (according to the NIH guideline) were treated with conventional treatment regimens (controls) as well as in combination with oral administration of colchicine plus herbal phenolic monoterpene fractions (intervention arm). After randomization, each group received the mentioned treatments and were evaluated for different variables including mortality, hospitalization duration, intensive care unit (ICU) administration ratios as well as laboratory variables such as leukocytes and lymphocytes count. The follow-up period considered as 2 weeks after discharge. The mentioned variables were assessed as before and after receiving the treatment in each group as well as intergroup analysis for comparing both baseline and final values.

NCT ID: NCT04392778 Completed - Covid19 Clinical Trials

Clinical Use of Stem Cells for the Treatment of Covid-19

Start date: April 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This study aims to use the regenerative and repair abilities of stem cells to fight against the harmful effects of the novel coronavirus Covid-19 and therefore develop a treatment strategy. It is known that fatalities from this virus is largely caused by its damage to lungs and other organs. As the disease progresses, these organs fail and lead to mortality. Our hope is that the stem cell transplantation from healthy donors will repair the damage caused by the virus and result in a healthy recovery.

NCT ID: NCT04395755 Completed - COVID-19 Clinical Trials

Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed

Start date: April 1, 2020
Phase:
Study type: Observational

Infertility is a severely distressing experience for many couples. Depression and anxiety are psychological disorders associated with infertility, and they may worsen during infertility treatments. This study times to understand the changes in the psychological status of infertile patients who had in vitro fertilization (IVF) treatment interrupted or postponed because of the COVID-19 pandemic.

NCT ID: NCT04406090 Completed - Ischemic Stroke Clinical Trials

Endovascular Thrombectomy in COVID-19 Infected Patients

ET-COVID-19
Start date: April 1, 2020
Phase:
Study type: Observational

About 5% of COVID-19 patients may present symptoms related to acute ischemic stroke (AIS). Treatment-management and outcomes related to mechanical thrombectomy (MT) for COVID-19 infected patients harboring large vessel occlusion is largely unknown. This multicentric study aims to investigate morbidity, mortality and neurological outcomes after MT performed in patients with COVID-19 infection.

NCT ID: NCT04406571 Completed - Clinical trials for Pancreatic Adenocarcinoma

Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

CAPANCOVID-19
Start date: April 1, 2020
Phase:
Study type: Observational

Pancreatic adenocarcinoma will be the 2nd cause of death by cancer in Europe in 2030. Pancreatic adenocarcinoma has poor prognosis with an all-stages combined 5-year survival rate below 8%. Since December 2019, a new coronavirus (Severe Acute Respiratory Syndrome Corona Virus 2, SARS-CoV-2) is responsible of COVID-19 infection with potentially severe respiratory syndrome or even multi-organ failure. An increased risk of severe COVID-19 infection in cancer patients is suggested in several Chinese series. Cancer care structures quickly reorganized to limit high-risk situations (diagnostic procedure, major surgery, cytotoxic poly-chemotherapy) and use alternatives such as on-hold chemotherapy. These reorganizations could be associated with a loss of chance for pancreatic adenocarcinoma.

NCT ID: NCT04420416 Completed - Depression, Anxiety Clinical Trials

Mental Health and Academic Performance in COVID-19

PANDEMIC
Start date: April 1, 2020
Phase:
Study type: Observational

This study aims to identify the preference of the class modalities (classroom or online) in undergraduate and graduate students. Additionally, to explore if the presence of any mental state alterations such as depression or anxiety due to the COVID-19 pandemic can alter their perception of academic performance.